CANBERRA: Orion Health Group had revenue growth of 26% to $207 million, up from $164 million the previous year. In FY16, annualised recurring revenue grew 36% to $85 million. Recurring revenue was 42% of operating revenue, compared with 33% in the previous year.
CEO Ian McCrae said FY16 has been a year of progress for the company, investing in the development and launch of the Amadeus prevision medicine platform.